SF1440 Summary

• Adds tramadol, butalbital, and gabapentin to the list of controlled substances monitored under Minnesota's prescription monitoring program.

• Makes the Prescription Monitoring Program Advisory Task Force permanent by removing its expiration date and ensuring it continues indefinitely under section 15.059.

• Establishes data retention limits: data from January 1, 2015 through December 31, 2018 may be retained through December 31, 2019; effective January 1, 2020, data older than 24 months must be destroyed and all new data must be destroyed within 12 months of receipt.

• Expands direct electronic access to prescription monitoring data to include personnel or designees of health-related licensing boards conducting investigations into inappropriate prescribing by specific licensees.

• Requires all prescribers licensed by health-related licensing boards and all pharmacists authorized to prescribe controlled substances to register and maintain user accounts with the prescription monitoring program by July 1, 2017.